Skip to content

4Accepted Apr 12, 5:36 PM ET

Ballantyne Charles Evan 4

GANXGain Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:36 PM

Apr 12, 2023

Filed

Apr 12, 2023

Documents

1

Size

8.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.